HNHPF(HNHPF)
HNHPF
No analyst ratings available
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $10.37T | $12.76T | $15.37T |
| Low | $9.62T | $10.03T | $13.05T |
| High | $11.07T | $15.62T | $17.73T |
| EBITDA Avg | $504.89B | $621.24B | $748.21B |
| Low | $468.25B | $488.02B | $635.41B |
| High | $538.85B | $760.12B | $862.98B |
| EBIT Avg | $379.57B | $467.04B | $562.49B |
| Low | $352.02B | $366.88B | $477.69B |
| High | $405.10B | $571.44B | $648.78B |
| Net Income Avg | $252.53B | $305.17B | $354.99B |
| Low | $203.03B | $245.36B | $285.41B |
| High | $302.88B | $366.03B | $425.77B |
| EPS Avg | $35.74 | $43.19 | $50.24 |
| Low | $28.74 | $34.73 | $40.40 |
| High | $42.87 | $51.81 | $60.26 |
| Analysts (Rev / EPS) | 18 / 1 | 19 / 1 | 8 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $2.71T | $3.25T | $2.87T | $3.00T | $3.30T | $3.68T |
| Low | $2.50T | $3.00T | $2.65T | $2.77T | $3.05T | $3.40T |
| High | $2.97T | $3.56T | $3.15T | $3.29T | $3.62T | $4.04T |
| EBITDA Avg | $131.83B | $158.09B | $139.75B | $146.00B | $160.77B | $179.32B |
| Low | $121.63B | $145.86B | $128.94B | $134.71B | $148.33B | $165.45B |
| High | $144.56B | $173.36B | $153.25B | $160.10B | $176.29B | $196.64B |
| EBIT Avg | $99.11B | $118.85B | $105.06B | $109.76B | $120.86B | $134.81B |
| Low | $91.44B | $109.65B | $96.94B | $101.27B | $111.51B | $124.38B |
| High | $108.68B | $130.33B | $115.21B | $120.36B | $132.54B | $147.83B |
| Net Income Avg | $75.40B | $87.29B | $74.31B | $80.30B | $89.22B | $99.50B |
| Low | $67.82B | $78.52B | $66.83B | $72.22B | $80.24B | $89.50B |
| High | $84.87B | $98.25B | $83.64B | $90.38B | $100.42B | $111.99B |
| EPS Avg | $9.43 | $10.91 | $9.29 | $10.04 | $11.15 | $12.44 |
| Low | $8.48 | $9.82 | $8.36 | $9.03 | $10.03 | $11.19 |
| High | $10.61 | $12.28 | $10.46 | $11.30 | $12.56 | $14.00 |
| Analysts (Rev / EPS) | 13 / 1 | 6 / 1 | 6 / 1 | 6 / 1 | 6 / 1 | 6 / 1 |